clinical trial · NCT06151197
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
Plantar FibromatosisLedderhose DiseaseEN3835Placebo
brief summary
This study will assess the efficacy, safety, and tolerability of EN3835 compared to placebo in the treatment of PFI (also known as Ledderhose disease).
started
Nov 28, 2023
primary completion
Jun 1, 2026
completion
Jun 1, 2026
last updated
Jun 9, 2026
official title
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol